相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?
Richard J. Glassock
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?
Hiddo J. Lambers Heerspink et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Biomarkers and surrogate end points-the challenge of statistical validation
Marc Buyse et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Systems biology to battle vascular disease
Anna F. Dominiczak et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Systems biology: opening new avenues in clinical research
Franck Molina et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease
Justyna Jantos-Siwy et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria
Thomas E. Delea et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria
Michael L. Merchant et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard
Chris P. Lee et al.
VALUE IN HEALTH (2009)
Urinary proteomics in diabetes and CKD
Kasper Rossing et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Nish Chaturvedi et al.
LANCET (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy
Hasan H. Otu et al.
DIABETES CARE (2007)
Advances in urinary proteome analysis and biomarker discovery
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Surrogate end points for clinical trials of kidney disease progression
Lesley A. Stevens et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns
K Rossing et al.
KIDNEY INTERNATIONAL (2005)
分享论文
